Type I Collagen: A Comprehensive Analysis of Its Definition, Diverse Applications and Experimental Application Guidelines

1 Definition and Structural Characteristics of Type I Collagen

Collagen is the most abundant protein in animals, accounting for approximately 25%-30% of total human protein. It is widely distributed in bones, tendons, tendon sheaths, ligaments, aponeuroses, cartilages and skins, serving as an essential component of connective tissues. Among all collagen types, Type I Collagen has the broadest distribution and highest content, making up around 90% of total human collagen. It provides mechanical support and maintains structural integrity for numerous tissues and organs.

In terms of molecular structure, Type I Collagen is a heterotrimer composed of two α1 chains and one α2 chain, with each polypeptide chain containing more than 1000 amino acids. The three polypeptide chains twist together to form a unique and stable triple helix structure. This regular and compact conformation is derived from the repetitive glycine-proline-hydroxyproline triplet in its primary sequence, forming a robust right-handed triple superhelix like three intertwined ropes. This distinctive structure endows collagen with excellent tensile strength, enabling it to resist external tension and provide structural support and protection for tissues.

Type I Collagen is predominantly located in tissues requiring high mechanical strength, including skin, bone, tendon, ligament and tooth. In the dermis, it constitutes the major structural component and coexists with finer Type III collagen fibers to endow the skin with toughness and elasticity. In bone tissue, Type I Collagen accounts for over 80% of organic components, acting as a framework for mineral deposition and sustaining bone strength and toughness. In tendons, it assembles into thick and well-organized fiber bundles with ultra-high tensile strength, ensuring efficient force transmission from muscles to bones.

The essential differences between Type I Collagen and other collagen types lie in amino acid composition, triple helix conformation and fiber morphology. Compared with Type II Collagen mainly present in cartilages and Type III Collagen abundant in infant skin and vascular intima, Type I Collagen forms thicker and firmer fibers, which explains its predominance in tissues requiring high-strength structural support. Notably, Type I Collagen can spontaneously assemble into triple helix scaffolds under neutral conditions. This property is critical for maintaining skin elasticity, bone strength and tendon toughness, and also makes it a highly valuable biomaterial in tissue engineering and regenerative medicine.

2 Versatile Applications of Type I Collagen

As a natural biological resource, Type I Collagen exhibits extensive application prospects owing to its excellent biocompatibility and biodegradability. It features low immunogenicity, high tensile strength, hemostatic property and cell proliferation-promoting activity, outperforming synthetic polymers as a superior biomaterial.

2.1 Tissue Engineering and Regenerative Medicine

In the field of tissue engineering, Type I Collagen is an ideal candidate for constructing biological scaffolds. It can mimic the three-dimensional microenvironment of native extracellular matrix (ECM) and facilitate cell adhesion, proliferation and differentiation. Studies have verified that collagen hydrogels with different stiffness can be prepared by adjusting collagen concentration to simulate mechanical properties of diverse tissues and regulate cellular behaviors. For instance, high-stiffness hydrogel (4 mg/mL) inhibits the migration of NK-92MI cells, while low-stiffness hydrogel (1 mg/mL) allows cells to migrate and spread freely.

In bone tissue engineering, Type I Collagen, as the major organic component of bone ECM, is widely used as scaffold material. It can be fabricated into various forms including sponges, particles and hydrogels to meet diverse experimental demands. Despite favorable biocompatibility and osteoconductive capacity, Type I Collagen still has limitations such as susceptibility to biodegradation, insufficient mechanical strength and lack of osteoinductivity. Therefore, continuous efforts are made to optimize the performance of collagen-based bone implants.

2.2 Medical Applications

Type I Collagen has a long application history and broad prospects in medical fields. It serves as surgical suture fiber and substrate for collagen detection in clinical practice. In recent years, Type I Collagen membranes have attracted increasing attention for injured tendon repair. Research demonstrates that wrapping damaged tendons with Type I Collagen membranes can effectively reduce peritendinous adhesion and promote endogenous tendon healing.

In an experiment using SD rat tendon injury models, the experimental group was treated with Type I Collagen membrane wrapping after tendon repair, while the control group received direct wound closure. Results showed that tendons in the experimental group were smoother with minimal adhesion to surrounding tissues. Tendon cells and collagen fibers were arranged in a linear and highly ordered pattern. By contrast, obvious adhesion and disorganized collagen arrangement were observed in the control group. Immunofluorescence assay further confirmed that the expression level of Type I Collagen in the experimental group was significantly higher (P<0.05), accompanied by more regular collagen fiber alignment (P<0.05). These results prove that Type I Collagen membrane can remarkably facilitate endogenous healing of injured tendons.

Similar results were obtained in chicken tendon injury models, which validated the anti-adhesion effect of bovine Type I Collagen membrane after tendon surgery. The biomaterial creates a favorable microenvironment for tendon repair, prevents premature ingrowth of fibrous tissues into the wound area, and guides ordered growth of tendon cells to optimize the healing process.

2.3 Cell Culture and Drug Delivery

Type I Collagen plays an important role in cell culture systems. As a substrate for 2D or 3D culture, it provides a growth microenvironment similar to in vivo conditions for various cell types. Three-dimensional collagen hydrogels can better recapitulate native cellular microenvironments and mechanical stimuli. Such 3D culture systems exert prominent regulatory effects on immune cell functions, including morphology, migration velocity and cytotoxicity of NK cells.

In the field of drug delivery systems, Type I Collagen has become a promising biomaterial due to its high drug loading capacity, favorable biocompatibility and biodegradability. Collagen-based drug delivery systems (CDSS) can carry multiple active agents including antibiotics, anti-inflammatory drugs and growth factors to realize controlled release and targeted delivery. Studies have shown that collagen/alginate composites are applicable to ocular drug delivery, and collagen/chitosan systems can be used for myocardial infarction treatment. The modular property of collagen enables the fabrication of customized drug delivery systems tailored to individual clinical requirements and disease conditions.

3 Experimental Guidelines for Type I Collagen

3.1 Experiments for Tissue Engineering Construction

In tissue engineering research, Type I Collagen is mainly used to fabricate three-dimensional biological scaffolds to simulate the microenvironment of native extracellular matrix. Experimentally, Type I Collagen is commonly extracted from rat tail tendons via acid extraction to obtain collagen solution. Hydrogels with different stiffness can be prepared by adjusting collagen concentration to satisfy the requirements of various tissue engineering researches.

In cartilage tissue engineering, three groups of collagen hydrogels with concentrations of 12, 8 and 6 mg/mL are prepared and labeled as C12, C8 and C6 respectively. With the increase of collagen concentration from 6 mg/mL to 12 mg/mL, significant changes occur in physicochemical properties: the fibrous network observed under scanning electron microscope becomes denser; the swelling rate increases gradually; the compressive modulus rises sequentially to (4.86 ± 0.96) kPa, (7.09 ± 2.33) kPa and (11.08 ± 3.18) kPa, with statistically significant differences among groups (P < 0.05). These variations in physical properties directly affect cellular behaviors. Researches indicate that hydrogels at 12 mg/mL possess superior physicochemical properties, while the expression levels of genes related to chondrocyte fibrosis and hypertrophy are also upregulated.

In vascularized tissue engineering, Type I Collagen hydrogel serves as a co-culture scaffold for human placental mesenchymal stem cells (HPMSCs) and human umbilical vein endothelial cells (HUVECs) to facilitate the formation of 3D vascular networks. Studies show that co-culture of HPMSCs and HUVECs derived from the same donor on collagen scaffolds presents more obvious angiogenic tendency, better network continuity and richer layered structure compared with cells from different donors. On day 7, the total vessel length and node number in the autologous cell group reach (8.11 ± 0.62) mm/mm² and (21.30 ± 1.41) nodes/mm² respectively, which are significantly higher than (6.68 ± 0.35) mm/mm² and (17.10 ± 1.10) nodes/mm² in the allogeneic cell group.

3.2 Cell Biology Research

Type I Collagen is widely applied in cell biology researches focusing on cell behaviors, migration and functions. Hydrogels with distinct stiffness are prepared to explore the effects of mechanical microenvironment on cellular activities.

In NK cell function assays, low-stiffness Type I Collagen hydrogel (10.97±2.10 Pa) and high-stiffness hydrogel (114.50±3.40 Pa) are prepared. After culturing NK-92MI cells in these hydrogels, distinct cellular phenotypes are observed. Compared with cells in low-stiffness hydrogel, NK-92MI cells in high-stiffness hydrogel exhibit a more elongated morphology (P<0.05), decreased average cell area (from (69.88±26.97) μm² to (46.59±21.62) μm²), reduced circularity, lower migration velocity (from (2.50±0.91) μm/min to (1.70±0.72) μm/min) and shorter migration distance (from (147.10±53.74) μm to (98.03±40.95) μm).

Furthermore, cytotoxicity assays reveal that after 24-hour culture, NK-92MI cells in high-stiffness hydrogel promote the proliferation of DLD-1 cells (proliferation rate increases from (46.39±12.79)% to (65.87±4.45)%) and show impaired cytotoxicity, and similar results are observed after 48 hours of incubation. These findings demonstrate that 3D culture microenvironments constructed by Type I Collagen hydrogels with different stiffness can alter the morphology, migration capacity and cytotoxic activity of NK-92MI cells, laying a foundation for exploring the mechanism how biomechanical microenvironment regulates NK cell immune responses.

3.3 Applications in Immunological Research

In immunological studies, Type I Collagen is used to evaluate immune cell functions and immune response mechanisms. The constructed 3D collagen hydrogel microenvironment can better recapitulate the interactions between immune cells and extracellular matrix in vivo, thus generating more physiologically relevant experimental data.

In the above NK cell researches, Type I Collagen hydrogel acts as a controllable 3D microenvironment for precise analysis of stiffness effects on immune cell functions. This culture system is more physiologically relevant than traditional 2D culture, as cells reside in complex 3D microenvironments in vivo. The biomechanical cues in 3D culture are much closer to native conditions, enabling more reliable experimental results.

3.4 Experiments for Drug Delivery Research

In drug delivery research, Type I Collagen serves as a drug carrier to investigate release kinetics and targeting efficiency. Various drugs and bioactive substances can be loaded into collagen matrix to study release profiles and therapeutic effects.

Collagen-based drug delivery systems (CDSS) can encapsulate a wide range of active ingredients, including:

• Anti-inflammatory drugs: e.g., Ketorolac for inflammation treatment
• Growth factors: e.g., NGF-β (Nerve Growth Factor-β) for sustained delivery and corneal regeneration
• Natural bioactive components: e.g., Royal jelly, Curcumin for wound healing
• Anti-cancer drugs: e.g., 5-Fluorouracil (5-FU) for tumor therapy

These collagen-based delivery systems can be engineered with diverse release kinetics to achieve rapid release or long-term sustained release according to therapeutic demands. For example, collagen/alginate composites are applied to ocular drug delivery, and collagen/chitosan systems are developed for myocardial infarction treatment.

4 Experimental Design and Technical Tips

4.1 Key Techniques for Preparing Type I Collagen Hydrogel

Several key points should be noted for successful preparation of Type I Collagen hydrogel. Firstly, collagen solution extraction is the primary step. For Type I Collagen isolated from rat tail tendons, 0.1% sterile acetic acid is used for dissolution. The mixture is centrifuged at 15000 r/min for 1 hour, and the supernatant is collected, dialyzed repeatedly and lyophilized. The obtained lyophilized collagen is re-dissolved in 0.1% sterile acetic acid to prepare stock solution at 10 mg/mL.

For hydrogel fabrication, collagen stock solution is mixed with appropriate volume of 10×α-MEM and cell culture medium to prepare premixed solution. The pH value is adjusted to 7.4 using 0.1 mol/L NaOH, followed by incubation at 37 ℃ for 1 hour for gelation, so as to obtain low-stiffness and high-stiffness hydrogels. The preparation protocols for 1 mg/mL (low stiffness) and 4 mg/mL (high stiffness) hydrogels are shown below:

• Low-stiffness hydrogel: Mix 100 μL Type I Collagen solution (10 mg/mL) with 10 μL 10×α-MEM, add approximately 90 μL 0.1 mol/L NaOH to adjust pH to 7.4, then blend with 800 μL cell suspension.
• High-stiffness hydrogel: Mix 400 μL Type I Collagen solution (10 mg/mL) with 40 μL 10×α-MEM, add approximately 160 μL 0.1 mol/L NaOH to adjust pH to 7.4, then blend with 400 μL cell suspension.

4.2 Characterization Methods for Hydrogel Properties

Comprehensive characterization of physicochemical properties is required for prepared collagen hydrogels, mainly including:

• Microstructure observation: Observe fibrous structure via laser confocal scanning microscope, and keep consistent imaging parameters for all samples.
• Rheological measurement: Perform amplitude sweep and frequency sweep with rheometer to detect hydrogel stiffness. The average storage modulus (G') in the plateau region is recorded as the stiffness value.
• Swelling property test: Immerse hydrogels in buffer solution for a certain period (e.g. 192 h) and calculate swelling rate to evaluate water absorption capacity.
• Compressive modulus test: Detect compressive modulus using mechanical tester to assess mechanical strength.

4.3 Notes for Cell Experiments

The following points should be taken into consideration during cell experiments in Type I Collagen hydrogels:

• Cell seeding density: Optimize cell seeding density according to experimental purposes. For example, approximately 1×10⁶ cells are mixed with collagen premixed solution in NK cell function research.
• Culture duration: Determine appropriate incubation time based on research objectives. Short-term culture (e.g. 24 h) is applied for cell morphology and migration observation, while long-term culture (e.g. 14 d) is used for cell differentiation and tissue formation evaluation.
• Selection of analytical methods: Choose detection approaches according to research targets:
  • Cell morphology analysis: Analyze cell area, circularity and aspect ratio using Image J software.
  • Migration tracking: Record cell migration process via high-content imaging system with 1-second interval for continuous 1-hour acquisition.
  • Gene expression analysis: Detect related gene expression by real-time quantitative PCR.
  • Histological staining: Observe tissue morphology and component distribution via HE staining, Toluidine blue staining and other staining methods.

5 Summary and Future Perspectives

As a natural biomaterial, Type I Collagen possesses irreplaceable value in scientific research and medical applications. It acts as a powerful research tool and experimental platform covering basic cell behavior analysis, complex tissue engineering construction, fundamental mechanism exploration and clinical therapeutic applications.

With the advancement of scientific technologies, Type I Collagen will have broader application prospects. Future research directions mainly include:

1. Develop more sophisticated 3D models to better simulate the complexity of in vivo microenvironments;
2. Optimize composite application of collagen with other biomaterials to overcome the limitations of single collagen material;
3. Explore the application of collagen in personalized medicine and design biomaterials tailored to individual patient demands;
4. Further investigate the interactions between collagen and various immune cells to provide new strategies for immunotherapy.

Researches and applications of Type I Collagen fully reflect the close integration of basic biology and clinical practice. With in-depth understanding of this classical biomolecule, Type I Collagen will continue to play a pivotal role in scientific development and medical progress, and make greater contributions to human health and quality of life.

Absin Type I Collagen Product Recommendations

Contact Absin

Absin provides antibodies, proteins, ELISA kits, cell culture, detection kits, and other research reagents. If you have any product needs, please contact us.

Absin Bioscience Inc. worldwide@absin.cn

Follow us on Facebook: Absin Bio